Researcher appreciation event · Save up to 30% when you bundle  |  First order? Enjoy 20% off
$199+ Free 2-day shipping$299+ Free peptide$599+ Another free peptide
✳PURE LAB PEPTIDESEMPOWERING RESEARCH
PRODUCT DOCUMENTATION

COA & Testing Results

Browse lot-specific certificate records for products in this catalog. Each entry summarizes information shown in a supplied report, including reported purity or content, test date, and report details where available. Open the linked document to review the complete certificate and confirm its lot matches your item.

Lot recordsBatch-specific documentation
Certificate detailsReported results at a glance
Supplied documentsOpen the linked certificate PDFs
HOW TO READ THESE RECORDS

Lot-specific certificate information

Each listing summarizes selected details shown in a document supplied for that product lot, such as the labeled material, lot number, test date, report details, methods, and reported results where available.

The summaries are a reading aid and do not replace the supplied certificate. Review the linked source document for the full record; results apply only to the sample described, and the source document controls if any details differ. Confirm the lot number against your item.

DOCUMENT LIBRARY

Search lot-specific documentation

Filter the supplied certificate records by product, lot number, strength, report number, test date, or other text shown in a listing.

SUPPLIER-PROVIDED CERTIFICATE SUMMARY

Pancragen · 20 mg · Lot 94940

Reported purity
99.001% HPLC

Tested
September 23, 2026

Report ID
40172

The supplied Pure Lab Peptides-branded summary identifies Chromate as the testing laboratory and states that the summary was prepared from an independent third-party source report. It also states the summary is not issued or signed by Chromate; use the original report as the controlling source.

Scope: The document states the results apply only to the tested sample as received. This site has not independently authenticated the report or verified that other inventory matches this lot.

Open supplied two-page PDF summary and analytical evidence ↗

Certificate summary
Pancragen · Lot 94940 · Report 40172
Supplier-provided Pure Lab Peptides certificate summary for Pancragen, lot 94940
Analytical evidence
RP-HPLC chromatogram · Lot 94940
Third-party source chromatogram for Pancragen lot 94940, report 40172
SUPPLIER-PROVIDED CERTIFICATE SUMMARY

Cardiogen · 20 mg · Lot 54233

Reported purity
99.768% HPLC

Tested
September 17, 2026

Report ID
39804

The supplied Pure Lab Peptides-branded summary identifies Chromate as the testing laboratory and states that the summary was prepared from an independent third-party source report. It also states the summary is not issued or signed by Chromate; use the original report as the controlling source.

The summary lists report date September 19, 2026, sample ID 39804, and molecular weight 489.48 g/mol. Scope: the document states the results apply only to the tested sample as received. This site has not independently authenticated the report or verified that other inventory matches this lot.

Open supplied two-page PDF summary and analytical evidence ↗

Certificate summary
Cardiogen · Lot 54233 · Report 39804
Supplier-provided Pure Lab Peptides certificate summary for Cardiogen, lot 54233
Analytical evidence
RP-HPLC chromatogram · Lot 54233
Third-party source chromatogram for Cardiogen lot 54233, report 39804
SUPPLIER-PROVIDED CERTIFICATE SUMMARY

Thymulin · 10 mg · Lot 61091

Reported purity
99.410% HPLC

Tested
September 17, 2026

Report ID
39798

The supplied Pure Lab Peptides-branded summary identifies Chromate as the testing laboratory and states that the summary was prepared from an independent third-party source report. It also states the summary is not issued or signed by Chromate; use the original report as the controlling source.

The summary lists report date September 19, 2026, sample ID 39798, CAS 63958-90-7, and molecular weight 858.86 g/mol. Scope: the document states the results apply only to the tested sample as received. This site has not independently authenticated the report or verified that other inventory matches this lot.

Open supplied two-page PDF summary and analytical evidence ↗

Certificate summary
Thymulin · Lot 61091 · Report 39798
Supplier-provided Pure Lab Peptides certificate summary for Thymulin, lot 61091
Analytical evidence
RP-HPLC chromatogram · Lot 61091
Third-party source chromatogram for Thymulin lot 61091, report 39798
SUPPLIER-PROVIDED CERTIFICATE SUMMARY

Vesugen · 20 mg · Lot 18854

Reported purity
99.892% HPLC

Tested
September 17, 2026

Report ID
39801

The supplied Pure Lab Peptides-branded summary identifies Chromate as the testing laboratory and states that the summary was prepared from an independent third-party source report. It also states the summary is not issued or signed by Chromate; use the original report as the controlling source.

The summary lists report date September 19, 2026, and sample ID 39801. Scope: the document states the results apply only to the tested sample as received. This site has not independently authenticated the report or verified that other inventory matches this lot.

Open supplied two-page PDF summary and analytical evidence ↗

Certificate summary
Vesugen · Lot 18854 · Report 39801
Supplier-provided Pure Lab Peptides certificate summary for Vesugen, lot 18854
Analytical evidence
RP-HPLC chromatogram · Lot 18854
Third-party source chromatogram for Vesugen lot 18854, report 39801
SUPPLIER-PROVIDED CERTIFICATE SUMMARY

Vilon · 20 mg · Lot 93894

Reported purity
99.064% HPLC

Tested
September 17, 2026

Report ID
39802

The supplied Pure Lab Peptides-branded summary identifies Chromate as the testing laboratory and states that the summary was prepared from an independent third-party source report. It also states the summary is not issued or signed by Chromate; use the original report as the controlling source.

The summary lists report date September 19, 2026, sample ID 39802, and CAS 45234-02-4. Scope: the document states the results apply only to the tested sample as received. This site has not independently authenticated the report or verified that other inventory matches this lot.

Open supplied two-page PDF summary and analytical evidence ↗

Certificate summary
Vilon · Lot 93894 · Report 39802
Supplier-provided Pure Lab Peptides certificate summary for Vilon, lot 93894
Analytical evidence
RP-HPLC chromatogram · Lot 93894
Third-party source chromatogram for Vilon lot 93894, report 39802
SUPPLIER-PROVIDED CERTIFICATE SUMMARY

Gonadorelin · 2 mg · Lot 35188

Reported purity
99.359% HPLC

Tested
September 15, 2026

Report ID
39812

The supplied Pure Lab Peptides-branded summary identifies Chromate as the testing laboratory and states that the summary was prepared from an independent third-party source report. It also states the summary is not issued or signed by Chromate; use the original report as the controlling source.

The summary lists report date September 19, 2026, sample ID 39812, and CAS 33515-09-2. Scope: the document states the results apply only to the tested sample as received. This site has not independently authenticated the report or verified that other inventory matches this lot.

Open supplied two-page PDF summary and analytical evidence ↗

Certificate summary
Gonadorelin · Lot 35188 · Report 39812
Supplier-provided Pure Lab Peptides certificate summary for Gonadorelin, lot 35188
Analytical evidence
RP-HPLC chromatogram · Lot 35188
Third-party source chromatogram for Gonadorelin lot 35188, report 39812
SUPPLIER-PROVIDED CERTIFICATE SUMMARY

GHRP-2 · 10 mg · Lot 89304

Reported purity
99.030% HPLC

Tested
September 14, 2026

Report ID
39709

The supplied Pure Lab Peptides-branded summary identifies Chromate as the testing laboratory and states that the summary was prepared from an independent third-party source report. It also states the summary is not issued or signed by Chromate; use the original report as the controlling source.

The summary lists report date September 14, 2026, sample ID 39709, CAS 158861-67-7, and molecular weight 817.99 g/mol. Scope: the document states the results apply only to the tested sample as received. This site has not independently authenticated the report or verified that other inventory matches this lot.

Open supplied two-page PDF summary and analytical evidence ↗

Certificate summary
GHRP-2 · Lot 89304 · Report 39709
Supplier-provided Pure Lab Peptides certificate summary for GHRP-2, lot 89304
Analytical evidence
RP-HPLC chromatogram · Lot 89304
Third-party source chromatogram for GHRP-2 lot 89304, report 39709
SUPPLIER-PROVIDED CERTIFICATE SUMMARY

GHRP-6 · 10 mg · Lot 71556

Reported purity
99.270% HPLC

Tested
September 14, 2026

Report ID
39707

The supplied Pure Lab Peptides-branded summary identifies Chromate as the testing laboratory and states that the summary was prepared from an independent third-party source report. It also states the summary is not issued or signed by Chromate; use the original report as the controlling source.

The summary lists report date September 14, 2026, sample ID 39707, CAS 87616-84-0, and molecular weight 873.03 g/mol. Scope: the document states the results apply only to the tested sample as received. This site has not independently authenticated the report or verified that other inventory matches this lot.

Open supplied two-page PDF summary and analytical evidence ↗

Certificate summary
GHRP-6 · Lot 71556 · Report 39707
Supplier-provided Pure Lab Peptides certificate summary for GHRP-6, lot 71556
Analytical evidence
RP-HPLC chromatogram · Lot 71556
Third-party source chromatogram for GHRP-6 lot 71556, report 39707
SUPPLIER-PROVIDED CERTIFICATE SUMMARY

GHRP-6 · 5 mg · Lot 86442

Reported purity
99.080% HPLC

Tested
September 14, 2026

Report ID
39706

The supplied Pure Lab Peptides-branded summary identifies Chromate as the testing laboratory and states that the summary was prepared from an independent third-party source report. It also states the summary is not issued or signed by Chromate; use the original report as the controlling source.

The summary lists report date September 14, 2026, sample ID 39706, CAS 87616-84-0, and molecular weight 873.03 g/mol. Scope: the document states the results apply only to the tested sample as received. This site has not independently authenticated the report or verified that other inventory matches this lot.

Open supplied two-page PDF summary and analytical evidence ↗

Certificate summary
GHRP-6 · Lot 86442 · Report 39706
Supplier-provided Pure Lab Peptides certificate summary for GHRP-6, lot 86442
Analytical evidence
RP-HPLC chromatogram · Lot 86442
Third-party source chromatogram for GHRP-6 lot 86442, report 39706
SUPPLIER-PROVIDED CERTIFICATE SUMMARY

Adamax · 10 mg · Lot 58026

Reported purity
99.564% HPLC

Tested
September 13, 2026

Report ID
39662

The supplied Pure Lab Peptides-branded summary identifies Chromate as the testing laboratory and states that the summary was prepared from an independent third-party source report. It also states the summary is not issued or signed by Chromate; use the original report as the controlling source.

The summary lists report date September 13, 2026, sample ID 39662, CAS not available, and molecular weight 1032.22 g/mol. Scope: the document states the results apply only to the tested sample as received. This site has not independently authenticated the report or verified that other inventory matches this lot.

Open supplied two-page PDF summary and analytical evidence ↗

Certificate summary
Adamax · Lot 58026 · Report 39662
Supplier-provided Pure Lab Peptides certificate summary for Adamax, lot 58026
Analytical evidence
RP-HPLC chromatogram · Lot 58026
Third-party source chromatogram for Adamax lot 58026, report 39662
SUPPLIER-PROVIDED ORIGINAL CERTIFICATE

5-Amino-1MQ · 10 mg · Lot 61611

Reported HPLC purity
99.8%

Date tested
August 11, 2026

BTLabs report
COA261057-011

Potency result: 11.8 mg (118.4%) against the certificate-stated 90–110% of 10 mg specification. This reported value is above that stated range. The certificate also reports a peptide-to-excipients ratio of 1:5.2. Results apply only to the sample as received; this site has not independently authenticated the report or matched other inventory to this lot.

View original two-page BTLabs certificate ↗

SUPPLIER-PROVIDED ORIGINAL CERTIFICATE

AOD-9604 · 5 mg · Lot 99766

Reported HPLC purity
99.7%

Date tested
August 11, 2026

BTLabs report
COA261057-024

The certificate reports potency of 4.8 mg (95.5%) against a 90–110% specification, and a peptide-to-excipients ratio of 1:13.9 versus the stated recommended range of 1:2 to 1:10. The ratio is outside that recommendation. Results apply only to the sample as received; this site has not independently authenticated the report or matched other inventory to this lot.

View original two-page BTLabs certificate ↗

SUPPLIER-PROVIDED ORIGINAL CERTIFICATE

Bacteriostatic Water · 10 mL · Lot 11538

Reported HPLC purity
99.7%

Date tested
August 11, 2026

BTLabs report
COA261057-028

The certificate reports potency of 8.9 mg (99.7%) and states that its testing does not assess particulate matter, microbial contamination, or endotoxins. Results apply only to the sample as received; this site has not independently authenticated the report or matched other inventory to this lot.

View original two-page BTLabs certificate ↗

SUPPLIER-PROVIDED ORIGINAL CERTIFICATE

Cagrilintide · 5 mg · Lot 66516

Reported HPLC purity
99.7%

Date tested
August 11, 2026

BTLabs report
COA261057-023

Potency result: 5.6 mg (112.6%) against a stated 90–110% specification, above that range. The certificate also reports a peptide-to-excipients ratio of 1:15.4 versus the stated recommended range of 1:2 to 1:10. Results apply only to the sample as received; this site has not independently authenticated the report or matched other inventory to this lot.

View original two-page BTLabs certificate ↗

SUPPLIER-PROVIDED ORIGINAL CERTIFICATE

Cartalax · 20 mg · Lot 17421

Reported HPLC purity
99.6%

Date tested
August 11, 2026

BTLabs report
COA261057-015

The certificate reports potency of 19.9 mg (99.7%) against a 90–110% specification and a peptide-to-excipients ratio of 1:3.1 against the stated recommended range of 1:2 to 1:10. Results apply only to the sample as received; this site has not independently authenticated the report or matched other inventory to this lot.

View original two-page BTLabs certificate ↗

SUPPLIER-PROVIDED ORIGINAL CERTIFICATE

CJC-1295 DAC · 2 mg · Lot 13878

Reported HPLC purity
99.6%

Date tested
August 11, 2026

BTLabs report
COA261057-026

The certificate reports potency of 2.1 mg (104.8%) against a 90–110% specification, and a peptide-to-excipients ratio of 1:20.4 versus the stated recommended range of 1:2 to 1:10. The ratio is outside that recommendation. Results apply only to the sample as received; this site has not independently authenticated the report or matched other inventory to this lot.

View original two-page BTLabs certificate ↗

SUPPLIER-PROVIDED ORIGINAL CERTIFICATE

CJC-1295 no-DAC · 2 mg · Lot 70803

Reported HPLC purity
99.6%

Date tested
August 11, 2026

BTLabs report
COA261057-025

Potency result: 2.3 mg (116.1%) against a stated 90–110% specification, above that range. The certificate also reports a peptide-to-excipients ratio of 1:16.1 versus the stated recommended range of 1:2 to 1:10. Results apply only to the sample as received; this site has not independently authenticated the report or matched other inventory to this lot.

View original two-page BTLabs certificate ↗

SUPPLIER-PROVIDED ORIGINAL CERTIFICATE

Cortagen · 20 mg · Lot 14405

Reported HPLC purity
99.7%

Date tested
August 11, 2026

BTLabs report
COA261057-017

The certificate reports potency of 19.4 mg (96.9%) against a 90–110% specification, and a peptide-to-excipients ratio of 1:3.2 against the stated recommended range of 1:2 to 1:10. Results apply only to the sample as received; this site has not independently authenticated the report or matched other inventory to this lot.

View original two-page BTLabs certificate ↗

SUPPLIER-PROVIDED ORIGINAL CERTIFICATE

Kisspeptin · 10 mg · Lot 79548

Reported HPLC purity
99.9%

Date tested
August 11, 2026

BTLabs report
COA261057-013

Potency result: 11.3 mg (113.1%) against a stated 90–110% specification, above that range. The certificate reports a peptide-to-excipients ratio of 1:5.2 against its stated recommended range of 1:2 to 1:10. Results apply only to the sample as received; this site has not independently authenticated the report or matched other inventory to this lot.

View original two-page BTLabs certificate ↗

SUPPLIER-PROVIDED ORIGINAL CERTIFICATE

KLOW · 80 mg · Lot 33414

Reported HPLC purity
99.8%

Date tested
August 11, 2026

BTLabs report
COA261057-003

The certificate reports component assay results: GHK-Cu 48.9 mg (61.1%), KPV 12.6 mg (15.8%), BPC-157 12.7 mg (15.9%), and TB-500 8.4 mg (10.4%). It reports a peptide-to-excipients ratio of 1:1 versus its stated recommended range of 1:2 to 1:10. Results apply only to the sample as received; this site has not independently authenticated the report or matched other inventory to this lot.

View original two-page BTLabs certificate ↗

SUPPLIER-PROVIDED ORIGINAL CERTIFICATE

Melanotan II · 10 mg · Lot 74928

Reported HPLC purity
99.9%

Date tested
August 11, 2026

BTLabs report
COA261057-006

The certificate reports potency of 10.6 mg (106.2%) against a 90–110% specification, and a peptide-to-excipients ratio of 1:5.8 against its stated recommended range of 1:2 to 1:10. Results apply only to the sample as received; this site has not independently authenticated the report or matched other inventory to this lot.

View original two-page BTLabs certificate ↗

SUPPLIER-PROVIDED ORIGINAL CERTIFICATE

MOTS-c · 10 mg · Lot 26394

Reported HPLC purity
99.8%

Date tested
August 11, 2026

BTLabs report
COA261057-004

The certificate reports potency of 9.9 mg (99.5%) against a 90–110% specification and a peptide-to-excipients ratio of 1:6.6 against its stated recommended range of 1:2 to 1:10. Results apply only to the sample as received; this site has not independently authenticated the report or matched other inventory to this lot.

View original two-page BTLabs certificate ↗

SUPPLIER-PROVIDED ORIGINAL CERTIFICATE

MOTS-c · 20 mg · Lot 30294

Reported HPLC purity
99.9%

Date tested
August 11, 2026

BTLabs report
COA261057-012

Potency result: 24.7 mg (123.7%) against a stated 90–110% specification, above that range. The certificate reports a peptide-to-excipients ratio of 1:2 against its stated recommended range of 1:2 to 1:10. Results apply only to the sample as received; this site has not independently authenticated the report or matched other inventory to this lot.

View original two-page BTLabs certificate ↗

SUPPLIER-PROVIDED ORIGINAL CERTIFICATE

MOTS-c · 40 mg · Lot 11342

Reported HPLC purity
99.9%

Date tested
August 11, 2026

BTLabs report
COA261057-005

Potency result: 46 mg (115.1%) against a stated 90–110% specification, above that range. The certificate also reports a peptide-to-excipients ratio of 1:1.3 versus its stated recommended range of 1:2 to 1:10. Results apply only to the sample as received; this site has not independently authenticated the report or matched other inventory to this lot.

View original two-page BTLabs certificate ↗

SUPPLIER-PROVIDED ORIGINAL CERTIFICATE

NAD · 500 mg · Lot 31758

Reported HPLC purity
99.9%

Date tested
August 11, 2026

BTLabs report
COA261057-027

Potency result: 586.6 mg (117.3%) against a stated 90–110% specification, above that range. The certificate reports a peptide-to-excipients ratio of 1:0.4 versus its stated recommended range of 1:2 to 1:10. Results apply only to the sample as received; this site has not independently authenticated the report or matched other inventory to this lot.

View original two-page BTLabs certificate ↗

SUPPLIER-PROVIDED ORIGINAL CERTIFICATE

Ovagen · 20 mg · Lot 67774

Reported HPLC purity
99.6%

Date tested
August 11, 2026

BTLabs report
COA261057-020

The certificate reports potency of 21.4 mg (106.8%) against a 90–110% specification and a peptide-to-excipients ratio of 1:2.8 against its stated recommended range of 1:2 to 1:10. Results apply only to the sample as received; this site has not independently authenticated the report or matched other inventory to this lot.

View original two-page BTLabs certificate ↗

SUPPLIER-PROVIDED ORIGINAL CERTIFICATE

Ovagen · 20 mg · Lot 74421

Reported HPLC purity
99.6%

Date tested
August 11, 2026

BTLabs report
COA261057-019

The certificate reports potency of 21.1 mg (105.5%) against a 90–110% specification and a peptide-to-excipients ratio of 1:2.8 against its stated recommended range of 1:2 to 1:10. Results apply only to the sample as received; this site has not independently authenticated the report or matched other inventory to this lot.

View original two-page BTLabs certificate ↗

SUPPLIER-PROVIDED ORIGINAL CERTIFICATE

Pinealon · 20 mg · Lot 70114

Reported HPLC purity
99.7%

Date tested
August 11, 2026

BTLabs report
COA261057-022

The certificate reports potency of 21.4 mg (107.2%) against a 90–110% specification and a peptide-to-excipients ratio of 1:3 against its stated recommended range of 1:2 to 1:10. Results apply only to the sample as received; this site has not independently authenticated the report or matched other inventory to this lot.

View original two-page BTLabs certificate ↗

SUPPLIER-PROVIDED ORIGINAL CERTIFICATE

Selank · 5 mg · Lot 61489

Reported HPLC purity
99.9%

Date tested
August 11, 2026

BTLabs report
COA261057-007

The certificate reports potency of 4.8 mg (96.4%) against a 90–110% specification and a peptide-to-excipients ratio of 1:12.7 versus its stated recommended range of 1:2 to 1:10. Results apply only to the sample as received; this site has not independently authenticated the report or matched other inventory to this lot.

View original two-page BTLabs certificate ↗

SUPPLIER-PROVIDED ORIGINAL CERTIFICATE

SS-31 · 50 mg · Lot 99768

Reported HPLC purity
99.8%

Date tested
August 11, 2026

BTLabs report
COA261057-010

The certificate reports potency of 52 mg (104%) against a 90–110% specification and a peptide-to-excipients ratio of 1:2.3 against its stated recommended range of 1:2 to 1:10. Results apply only to the sample as received; this site has not independently authenticated the report or matched other inventory to this lot.

View original two-page BTLabs certificate ↗

SUPPLIER-PROVIDED ORIGINAL CERTIFICATE

ARA-290 · 16 mg · Lot 12183

Reported HPLC purity
99.7%

Date tested
July 15, 2026

BTLabs report
IF-824-QSA-TR006-BTL26955-01

The certificate reports potency of 16.8 mg (105.1%) against a 90–110% specification and a peptide-to-excipients ratio of 1:4 against its stated recommended range of 1:2 to 1:10. Results apply only to the sample as received; this site has not independently authenticated the report or matched other inventory to this lot.

View original two-page BTLabs certificate ↗

SUPPLIER-PROVIDED ORIGINAL CERTIFICATE

BPC-157 · 10 mg · Lot 58825

Reported HPLC purity
99.6%

Date tested
July 15, 2026

BTLabs report
IF-824-QSA-TR006-BTL26955-05

The certificate reports potency of 9.7 mg (97.3%) against a 90–110% specification and a peptide-to-excipients ratio of 1:7.4 against its stated recommended range of 1:2 to 1:10. Results apply only to the sample as received; this site has not independently authenticated the report or matched other inventory to this lot.

View original two-page BTLabs certificate ↗

SUPPLIER-PROVIDED ORIGINAL CERTIFICATE

BPC-157 · 5 mg · Lot 99716

Reported HPLC purity
99.7%

Date tested
July 15, 2026

BTLabs report
IF-824-QSA-TR006-BTL26955-06

The certificate reports potency of 4.7 mg (99.7%) against a 90–110% specification and a peptide-to-excipients ratio of 1:14.2 versus its stated recommended range of 1:2 to 1:10. Results apply only to the sample as received; this site has not independently authenticated the report or matched other inventory to this lot.

View original two-page BTLabs certificate ↗

SUPPLIER-PROVIDED ORIGINAL CERTIFICATE

CJC-1295 DAC · 5 mg · Lot 94072

Reported HPLC purity
99.7%

Date tested
July 15, 2026

BTLabs report
IF-824-QSA-TR006-BTL26955-07

Potency result: 5.6 mg (112.5%) against a stated 90–110% specification, above that range. The certificate reports a peptide-to-excipients ratio of 1:8 against its stated recommended range of 1:2 to 1:10. Results apply only to the sample as received; this site has not independently authenticated the report or matched other inventory to this lot.

View original two-page BTLabs certificate ↗

SUPPLIER-PROVIDED ORIGINAL CERTIFICATE

CJC-1295 no-DAC · 5 mg · Lot 99719

Reported HPLC purity
99.5%

Date tested
July 15, 2026

BTLabs report
IF-824-QSA-TR006-BTL26955-10

The certificate reports potency of 5.3 mg (105.6%) against a 90–110% specification and a peptide-to-excipients ratio of 1:8.7 against its stated recommended range of 1:2 to 1:10. Results apply only to the sample as received; this site has not independently authenticated the report or matched other inventory to this lot.

View original two-page BTLabs certificate ↗

SUPPLIER-PROVIDED ORIGINAL CERTIFICATE

GHK-Cu · 50 mg · Lot 83075

Reported HPLC purity
99.7%

Date tested
July 15, 2026

BTLabs report
IF-824-QSA-TR006-BTL26955-12

The certificate reports potency of 50.6 mg (101.2%) against a 90–110% specification and a peptide-to-excipients ratio of 1:1.8 versus its stated recommended range of 1:2 to 1:10. Results apply only to the sample as received; this site has not independently authenticated the report or matched other inventory to this lot.

View original two-page BTLabs certificate ↗

SUPPLIER-PROVIDED ORIGINAL CERTIFICATE

GLOW · 70 mg · Lot 99751

Reported HPLC purity
99.7%

Date tested
July 15, 2026

BTLabs report
IF-824-QSA-TR006-BTL26955-14

The certificate reports component assay results: GHK-Cu 50.3 mg (71.9%), BPC-157 11.5 mg (16.5%), and TB-500 10.2 mg (14.5%). It reports a peptide-to-excipients ratio of 1:1.1 versus the stated recommended range of 1:2 to 1:10. Results apply only to the sample as received; this site has not independently authenticated the report or matched other inventory to this lot.

View original two-page BTLabs certificate ↗

SUPPLIER-PROVIDED ORIGINAL CERTIFICATE

GLOW · 70 mg · Lot 99723

Reported HPLC purity
99.7%

Date tested
July 15, 2026

BTLabs report
IF-824-QSA-TR006-BTL26955-13

The certificate reports component assay results: GHK-Cu 49.7 mg (71%), BPC-157 10 mg (14.3%), and TB-500 12.1 mg (17.3%). It reports a peptide-to-excipients ratio of 1:1.7 versus the stated recommended range of 1:2 to 1:10. Results apply only to the sample as received; this site has not independently authenticated the report or matched other inventory to this lot.

View original two-page BTLabs certificate ↗

SUPPLIER-PROVIDED ORIGINAL CERTIFICATE

GLP1-S / Semaglutide · 20 mg · Lot 99756

Reported HPLC purity
99.9%

Date tested
July 15, 2026

BTLabs report
IF-824-QSA-TR006-BTL26955-17

The certificate reports potency of 20.7 mg (103.5%) against a 90–110% specification and a peptide-to-excipients ratio of 1:2.4 against its stated recommended range of 1:2 to 1:10. Results apply only to the sample as received; this site has not independently authenticated the report or matched other inventory to this lot.

View original two-page BTLabs certificate ↗

SUPPLIER-PROVIDED ORIGINAL CERTIFICATE

GLP1-S / Semaglutide · 20 mg · Lot 99725

Reported HPLC purity
99.8%

Date tested
July 15, 2026

BTLabs report
IF-824-QSA-TR006-BTL26955-16

The certificate reports potency of 20.2 mg (101.2%) against a 90–110% specification and a peptide-to-excipients ratio of 1:2.6 against its stated recommended range of 1:2 to 1:10. Results apply only to the sample as received; this site has not independently authenticated the report or matched other inventory to this lot.

View original two-page BTLabs certificate ↗

SUPPLIER-PROVIDED ORIGINAL CERTIFICATE

GLP1-S / Semaglutide · 20 mg · Lot 99756 · Report 45

Reported HPLC purity
99.9%

Date tested
July 15, 2026

BTLabs report
IF-824-QSA-TR006-BTL26955-45

This is a second supplied report for lot 99756, with a different BT Sample ID and report number from the other lot 99756 certificate. It reports potency of 20.6 mg (102.8%) and a peptide-to-excipients ratio of 1:2.5, within the stated ranges. Results apply only to the sample as received; this site has not independently authenticated the report or matched other inventory to this lot.

View original two-page BTLabs certificate ↗

SUPPLIER-PROVIDED ORIGINAL CERTIFICATE

GLP1-S / Semaglutide · 5 mg · Lot 13422

Reported HPLC purity
99.8%

Date tested
July 15, 2026

BTLabs report
IF-824-QSA-TR006-BTL26955-43

The certificate reports potency of 5.5 mg (110.8%), above its stated 90–110% specification; the peptide-to-excipients ratio is 1:8, within the stated recommended range. Results apply only to the sample as received; this site has not independently authenticated the report or matched other inventory to this lot.

View original two-page BTLabs certificate ↗

SUPPLIER-PROVIDED ORIGINAL CERTIFICATE

GLP2-T / Tirzepatide · 5 mg · Lot 99726

Reported HPLC purity
99.6%

Date tested
July 15, 2026

BTLabs report
IF-824-QSA-TR006-BTL26955-46

The certificate reports potency of 5.1 mg (102.2%) within its 90–110% specification. Its 1:17.3 peptide-to-excipients ratio is outside the stated recommended range of 1:2 to 1:10. Results apply only to the sample as received; this site has not independently authenticated the report or matched other inventory to this lot.

View original two-page BTLabs certificate ↗

SUPPLIER-PROVIDED ORIGINAL CERTIFICATE

GLP2-T / Tirzepatide · 10 mg · Lot 45543

Reported HPLC purity
99.7%

Date tested
July 15, 2026

BTLabs report
IF-824-QSA-TR006-BTL26955-47

The certificate reports potency of 10.3 mg (102.8%) and a peptide-to-excipients ratio of 1:8.9, both within its stated ranges. Results apply only to the sample as received; this site has not independently authenticated the report or matched other inventory to this lot.

View original two-page BTLabs certificate ↗

SUPPLIER-PROVIDED ORIGINAL CERTIFICATE

GLP2-T / Tirzepatide · 15 mg · Lot 97890

Reported HPLC purity
99.7%

Date tested
July 15, 2026

BTLabs report
IF-824-QSA-TR006-BTL26955-48

The certificate reports potency of 17 mg (113.5%), above its stated 90–110% specification; the peptide-to-excipients ratio is 1:5.7, within the stated recommended range. Results apply only to the sample as received; this site has not independently authenticated the report or matched other inventory to this lot.

View original two-page BTLabs certificate ↗

SUPPLIER-PROVIDED ORIGINAL CERTIFICATE

GLP2-T / Tirzepatide · 30 mg · Lot 99763

Reported HPLC purity
99.8%

Date tested
July 15, 2026

BTLabs report
IF-824-QSA-TR006-BTL26955-49

The certificate reports potency of 34.5 mg (115.1%), above its stated 90–110% specification. Its 1:1.3 peptide-to-excipients ratio is below the stated recommended range of 1:2 to 1:10. Results apply only to the sample as received; this site has not independently authenticated the report or matched other inventory to this lot.

View original two-page BTLabs certificate ↗

SUPPLIER-PROVIDED ORIGINAL CERTIFICATE

GLP2-T / Tirzepatide · 60 mg · Lot 99764

Reported HPLC purity
99.9%

Date tested
July 15, 2026

BTLabs report
IF-824-QSA-TR006-BTL26955-50

The certificate reports potency of 70.4 mg (117.3%), above its stated 90–110% specification. Its 1:0.7 peptide-to-excipients ratio is below the stated recommended range of 1:2 to 1:10. Results apply only to the sample as received; this site has not independently authenticated the report or matched other inventory to this lot.

View original two-page BTLabs certificate ↗

SUPPLIER-PROVIDED ORIGINAL CERTIFICATE

GLP2-T / Tirzepatide · 90 mg · Lot 99765

Reported HPLC purity
99.9%

Date tested
July 15, 2026

BTLabs report
IF-824-QSA-TR006-BTL26955-51

The certificate reports potency of 93.7 mg (104.1%) within its stated 90–110% specification. Its 1:0.6 peptide-to-excipients ratio is below the stated recommended range of 1:2 to 1:10. Results apply only to the sample as received; this site has not independently authenticated the report or matched other inventory to this lot.

View original two-page BTLabs certificate ↗

SUPPLIER-PROVIDED ORIGINAL CERTIFICATE

GLP3-R / Retatrutide · 10 mg · Lot 99760

Reported HPLC purity
99.7%

Date tested
July 15, 2026

BTLabs report
IF-824-QSA-TR006-BTL26955-53

The certificate reports potency of 10.1 mg (101.4%) and a peptide-to-excipients ratio of 1:8.7, within its stated ranges. Results apply only to the sample as received; this site has not independently authenticated the report or matched other inventory to this lot.

View original two-page BTLabs certificate ↗

SUPPLIER-PROVIDED ORIGINAL CERTIFICATE

GLP3-R / Retatrutide · 10 mg · Lot 80403

Reported HPLC purity
99.6%

Date tested
July 15, 2026

BTLabs report
IF-824-QSA-TR006-BTL26955-54

The certificate reports potency of 10.8 mg (108.2%) and a peptide-to-excipients ratio of 1:6, within its stated ranges. Results apply only to the sample as received; this site has not independently authenticated the report or matched other inventory to this lot.

View original two-page BTLabs certificate ↗

SUPPLIER-PROVIDED ORIGINAL CERTIFICATE

GLP3-R / Retatrutide · 20 mg · Lot 99761

Reported HPLC purity
99.8%

Date tested
July 15, 2026

BTLabs report
IF-824-QSA-TR006-BTL26955-55

The certificate reports potency of 21 mg (104.9%) and a peptide-to-excipients ratio of 1:3.3, within its stated ranges. Results apply only to the sample as received; this site has not independently authenticated the report or matched other inventory to this lot.

View original two-page BTLabs certificate ↗

SUPPLIER-PROVIDED ORIGINAL CERTIFICATE

GLP3-R / Retatrutide · 20 mg · Lot 74215

Reported HPLC purity
99.8%

Date tested
July 15, 2026

BTLabs report
IF-824-QSA-TR006-BTL26955-56

The certificate reports potency of 20.5 mg (102.4%) and a peptide-to-excipients ratio of 1:4.3, within its stated ranges. Results apply only to the sample as received; this site has not independently authenticated the report or matched other inventory to this lot.

View original two-page BTLabs certificate ↗

SUPPLIER-PROVIDED ORIGINAL CERTIFICATE

GLP3-R / Retatrutide · 30 mg · Lot 99762

Reported HPLC purity
99.8%

Date tested
July 15, 2026

BTLabs report
IF-824-QSA-TR006-BTL26955-57

The certificate reports potency of 30.5 mg (101.6%) and a peptide-to-excipients ratio of 1:3.3, within its stated ranges. Results apply only to the sample as received; this site has not independently authenticated the report or matched other inventory to this lot.

View original two-page BTLabs certificate ↗

SUPPLIER-PROVIDED ORIGINAL CERTIFICATE

GLP3-R / Retatrutide · 30 mg · Lot 46633

Reported HPLC purity
99.8%

Date tested
July 15, 2026

BTLabs report
IF-824-QSA-TR006-BTL26955-58

The certificate reports potency of 30.3 mg (100.9%) and a peptide-to-excipients ratio of 1:3.2, within its stated ranges. Results apply only to the sample as received; this site has not independently authenticated the report or matched other inventory to this lot.

View original two-page BTLabs certificate ↗

SUPPLIER-PROVIDED ORIGINAL CERTIFICATE

GLP3-R / Retatrutide · 40 mg · Lot 44884

Reported HPLC purity
99.8%

Date tested
July 15, 2026

BTLabs report
IF-824-QSA-TR006-BTL26955-59

The certificate reports potency of 44.3 mg (110.6%), slightly above its stated 90–110% specification. Its 1:1.7 peptide-to-excipients ratio is below the stated recommended range of 1:2 to 1:10. Results apply only to the sample as received; this site has not independently authenticated the report or matched other inventory to this lot.

View original two-page BTLabs certificate ↗

SUPPLIER-PROVIDED ORIGINAL CERTIFICATE

GLP2-T / Tirzepatide · 10 mg · Lot 73023

Reported HPLC purity
99.7%

Date tested
July 15, 2026

BTLabs report
IF-824-QSA-TR006-BTL26955-60

The certificate reports potency of 10.8 mg (107.8%) and a peptide-to-excipients ratio of 1:8.7, within its stated ranges. Results apply only to the sample as received; this site has not independently authenticated the report or matched other inventory to this lot.

View original two-page BTLabs certificate ↗

SUPPLIER-PROVIDED ORIGINAL CERTIFICATE

GLP3-R / Retatrutide · 5 mg · Lot 99759

Reported HPLC purity
99.7%

Date tested
July 15, 2026

BTLabs report
IF-824-QSA-TR006-BTL26955-52

The certificate reports potency of 5.8 mg (116.7%), above its stated 90–110% specification; the peptide-to-excipients ratio is 1:8.1, within the stated recommended range. Results apply only to the sample as received; this site has not independently authenticated the report or matched other inventory to this lot.

View original two-page BTLabs certificate ↗

SUPPLIER-PROVIDED ORIGINAL CERTIFICATE

Ipamorelin · 10 mg · Lot 99754

Reported HPLC purity
99.9%

Date tested
July 15, 2026

BTLabs report
IF-824-QSA-TR006-BTL26955-20

The certificate reports potency of 11.8 mg (117.9%), above its stated 90–110% specification; the peptide-to-excipients ratio is 1:3.8, within the stated recommended range. Results apply only to the sample as received; this site has not independently authenticated the report or matched other inventory to this lot.

View original two-page BTLabs certificate ↗

SUPPLIER-PROVIDED ORIGINAL CERTIFICATE

Ipamorelin · 5 mg · Lot 99733

Reported HPLC purity
99.9%

Date tested
July 15, 2026

BTLabs report
IF-824-QSA-TR006-BTL26955-21

The certificate reports potency of 5.3 mg (106.8%) and a peptide-to-excipients ratio of 1:9.1, within its stated ranges. Results apply only to the sample as received; this site has not independently authenticated the report or matched other inventory to this lot.

View original two-page BTLabs certificate ↗

SUPPLIER-PROVIDED ORIGINAL CERTIFICATE

MOTS-C · 40 mg · Lot 99753

Reported HPLC purity
99.9%

Date tested
July 15, 2026

BTLabs report
IF-824-QSA-TR006-BTL26955-28

The certificate reports potency of 49.1 mg (122.9%), above its stated 90–110% specification. Its 1:1.7 peptide-to-excipients ratio is below the stated recommended range of 1:2 to 1:10. Results apply only to the sample as received; this site has not independently authenticated the report or matched other inventory to this lot.

View original two-page BTLabs certificate ↗

SUPPLIER-PROVIDED ORIGINAL CERTIFICATE

Selank · 10 mg · Lot 49223

Reported HPLC purity
99.6%

Date tested
July 15, 2026

BTLabs report
IF-824-QSA-TR006-BTL26955-29

The certificate reports potency of 12.2 mg (121.9%), above its stated 90–110% specification; the peptide-to-excipients ratio is 1:5.3, within the stated recommended range. Results apply only to the sample as received; this site has not independently authenticated the report or matched other inventory to this lot.

View original two-page BTLabs certificate ↗

SUPPLIER-PROVIDED ORIGINAL CERTIFICATE

Semax · 10 mg · Lot 53308

Reported HPLC purity
99.8%

Date tested
July 15, 2026

BTLabs report
IF-824-QSA-TR006-BTL26955-31

The certificate reports potency of 11.7 mg (117%), above its stated 90–110% specification; the peptide-to-excipients ratio is 1:5.9, within the stated recommended range. Results apply only to the sample as received; this site has not independently authenticated the report or matched other inventory to this lot.

View original two-page BTLabs certificate ↗

SUPPLIER-PROVIDED ORIGINAL CERTIFICATE

Sermorelin · 5 mg · Lot 99708

Reported HPLC purity
99.6%

Date tested
July 15, 2026

BTLabs report
IF-824-QSA-TR006-BTL26955-33

The certificate reports potency of 5.2 mg (103.3%) within its stated 90–110% specification. Its 1:12.6 peptide-to-excipients ratio is outside the stated recommended range of 1:2 to 1:10. Results apply only to the sample as received; this site has not independently authenticated the report or matched other inventory to this lot.

View original two-page BTLabs certificate ↗

SUPPLIER-PROVIDED ORIGINAL CERTIFICATE

SS-31 · 10 mg · Lot 54604

Reported HPLC purity
99.9%

Date tested
July 15, 2026

BTLabs report
IF-824-QSA-TR006-BTL26955-34

The certificate reports potency of 11.5 mg (115.2%), above its stated 90–110% specification; the peptide-to-excipients ratio is 1:5.9, within the stated recommended range. Results apply only to the sample as received; this site has not independently authenticated the report or matched other inventory to this lot.

View original two-page BTLabs certificate ↗

SUPPLIER-PROVIDED ORIGINAL CERTIFICATE

TB-500 · 10 mg · Lot 49089

Reported HPLC purity
99.8%

Date tested
July 15, 2026

BTLabs report
IF-824-QSA-TR006-BTL26955-36

The certificate reports potency of 12.4 mg (124.3%), above its stated 90–110% specification; the peptide-to-excipients ratio is 1:5.2, within the stated recommended range. Results apply only to the sample as received; this site has not independently authenticated the report or matched other inventory to this lot.

View original two-page BTLabs certificate ↗

SUPPLIER-PROVIDED ORIGINAL CERTIFICATE

TB-500 · 10 mg · Lot 97379

Reported HPLC purity
99.8%

Date tested
July 15, 2026

BTLabs report
IF-824-QSA-TR006-BTL26955-37

The certificate reports potency of 11.1 mg (110.9%), slightly above its stated 90–110% specification; the peptide-to-excipients ratio is 1:5.5, within the stated recommended range. Results apply only to the sample as received; this site has not independently authenticated the report or matched other inventory to this lot.

View original two-page BTLabs certificate ↗

SUPPLIER-PROVIDED ORIGINAL CERTIFICATE

Tesamorelin · 5 mg · Lot 99750

Reported HPLC purity
99.7%

Date tested
July 15, 2026

BTLabs report
IF-824-QSA-TR006-BTL26955-40

The certificate reports potency of 5.5 mg (110.8%), above its stated 90–110% specification. Its 1:13.8 peptide-to-excipients ratio is outside the stated recommended range of 1:2 to 1:10. Results apply only to the sample as received; this site has not independently authenticated the report or matched other inventory to this lot.

View original two-page BTLabs certificate ↗

SUPPLIER-PROVIDED ORIGINAL CERTIFICATE

Tesamorelin / Ipamorelin · 10 mg · Lot 99747

Reported HPLC purity
99.9%

Date tested
July 15, 2026

BTLabs report
IF-824-QSA-TR006-BTL26955-41

The certificate reports separate component potency results: Ipamorelin 5.8 mg (58.5%) and Tesamorelin 6.2 mg (61.7%) against a 10 mg specification. It reports total peptide-to-excipients ratio 1:4.7 within the stated ratio range. The two individual percentages are presented as printed on the source. Results apply only to the sample as received; this site has not independently authenticated the report or matched other inventory to this lot.

View original two-page BTLabs certificate ↗

SUPPLIER-PROVIDED ORIGINAL CERTIFICATE

Tri-Heal · 45 mg · Lot 99712

Reported HPLC purity
99.6%

Date tested
July 15, 2026

BTLabs report
IF-824-QSA-TR006-BTL26955-42

The certificate lists component assay results: KPV 11.9 mg (26.4%), BPC-157 11.5 mg (25.6%), and TB-500 27.8 mg (60.8%). It reports a peptide-to-excipients ratio of 1:1.9, below the stated recommended range of 1:2 to 1:10. Results apply only to the sample as received; this site has not independently authenticated the report or matched other inventory to this lot.

View original two-page BTLabs certificate ↗

SUPPLIER-PROVIDED ORIGINAL CERTIFICATE

5-Amino-1MQ · 50 mg · Lot 54697

Reported HPLC purity
99.5%

Date tested
March 18, 2026

BTLabs report
IF-824-QSA-TR006-BTL2649-01

The certificate reports potency of 47.2 mg (94.5%) against a stated 90–110% specification and a peptide-to-excipients ratio of 1:2.6. The certificate lists PureLab Peptides as both customer and manufacturer. Results apply only to the sample as received; this site has not independently authenticated the report or matched other inventory to this lot.

View original two-page BTLabs certificate ↗

SUPPLIER-PROVIDED ORIGINAL CERTIFICATE

ARA-290 · 16 mg · Lot 20560

Reported HPLC purity
99.7%

Date tested
March 18, 2026

BTLabs report
IF-824-QSA-TR006-BTL2649-07

The certificate reports potency of 16.3 mg (101.8%) and a peptide-to-excipients ratio of 1:3.4, within its stated ranges. The certificate lists PureLab Peptides as both customer and manufacturer. Results apply only to the sample as received; this site has not independently authenticated the report or matched other inventory to this lot.

View original two-page BTLabs certificate ↗

SUPPLIER-PROVIDED ORIGINAL CERTIFICATE

BPC-157 / TB-500 · 10 mg · Lot 65192

Reported HPLC purity
99.8%

Date tested
March 18, 2026

BTLabs report
IF-824-QSA-TR006-BTL2649-08

The certificate lists component assays: BPC-157 5.9 mg (58.6%) and TB-500 6.03 mg (60.3%). It reports a peptide-to-excipients ratio of 1:5.2. The certificate lists PureLab Peptides as both customer and manufacturer. Results apply only to the sample as received; this site has not independently authenticated the report or matched other inventory to this lot.

View original two-page BTLabs certificate ↗

SUPPLIER-PROVIDED ORIGINAL CERTIFICATE

BPC-157 / TB-500 · 20 mg · Lot 48182

Reported HPLC purity
99.8%

Date tested
March 18, 2026

BTLabs report
IF-824-QSA-TR006-BTL2649-09

The certificate lists component assays: BPC-157 11.4 mg (57.1%) and TB-500 11.7 mg (58.3%). It reports a peptide-to-excipients ratio of 1:2.7. The certificate lists PureLab Peptides as both customer and manufacturer. Results apply only to the sample as received; this site has not independently authenticated the report or matched other inventory to this lot.

View original two-page BTLabs certificate ↗

SUPPLIER-PROVIDED ORIGINAL CERTIFICATE

Cagrilintide · 5 mg · Lot 14106

Reported HPLC purity
99.8%

Date tested
March 18, 2026

BTLabs report
IF-824-QSA-TR006-BTL2649-10

The certificate reports potency of 6 mg (119.1%), above its stated 90–110% specification. Its 1:15 peptide-to-excipients ratio is outside the stated recommended range of 1:2 to 1:10. The certificate lists PureLab Peptides as both customer and manufacturer. Results apply only to the sample as received; this site has not independently authenticated the report or matched other inventory to this lot.

View original two-page BTLabs certificate ↗

SUPPLIER-PROVIDED ORIGINAL CERTIFICATE

Chonluten · 20 mg · Lot 57568

Reported HPLC purity
99.4%

Date tested
March 18, 2026

BTLabs report
IF-824-QSA-TR006-BTL2649-12

The certificate reports potency of 22.2 mg (110.8%), above its stated 90–110% specification, and a peptide-to-excipients ratio of 1:2.3. The certificate lists PureLab Peptides as both customer and manufacturer. Results apply only to the sample as received; this site has not independently authenticated the report or matched other inventory to this lot.

View original two-page BTLabs certificate ↗

SUPPLIER-PROVIDED ORIGINAL CERTIFICATE

GLP3-R / Retatrutide · 20 mg · Lot 46743

Reported HPLC purity
99.7%

Date tested
March 18, 2026

BTLabs report
IF-824-QSA-TR006-BTL2649-14

The certificate reports potency of 19.8 mg (99.1%) and a peptide-to-excipients ratio of 1:5.1. The certificate lists PureLab Peptides as both customer and manufacturer; the supplied filename identifies this as GLP3-R. Results apply only to the sample as received; this site has not independently authenticated the report or matched other inventory to this lot.

View original two-page BTLabs certificate ↗

SUPPLIER-PROVIDED ORIGINAL CERTIFICATE

KPV · 10 mg · Lot 57460

Reported HPLC purity
99.5%

Date tested
March 18, 2026

BTLabs report
IF-824-QSA-TR006-BTL2649-13

The certificate reports potency of 11.1 mg (110.6%), slightly above its stated 90–110% specification. Its peptide-to-excipients ratio is 1:6, within the stated recommended range. Results apply only to the sample as received; this site has not independently authenticated the report or matched other inventory to this lot.

View original two-page BTLabs certificate ↗

SUPPLIER-PROVIDED ORIGINAL CERTIFICATE

Semax · 10 mg · Lot 22823

Reported HPLC purity
99.8%

Date tested
March 18, 2026

BTLabs report
IF-824-QSA-TR006-BTL2649-16

The certificate reports potency of 10.5 mg (104.6%) and a peptide-to-excipients ratio of 1:6.1, within its stated ranges. Results apply only to the sample as received; this site has not independently authenticated the report or matched other inventory to this lot.

View original two-page BTLabs certificate ↗

SUPPLIER-PROVIDED ORIGINAL CERTIFICATE

Semax · 5 mg · Lot 11376

Reported HPLC purity
99.7%

Date tested
March 18, 2026

BTLabs report
IF-824-QSA-TR006-BTL2649-15

The certificate reports potency of 5.1 mg (101.9%) and a peptide-to-excipients ratio of 1:9.1, within its stated ranges. Results apply only to the sample as received; this site has not independently authenticated the report or matched other inventory to this lot.

View original two-page BTLabs certificate ↗

SUPPLIER-PROVIDED ORIGINAL CERTIFICATE

SLU-PP-332 · 5 mg · Lot 70353-B

Reported HPLC purity
99.2%

Date tested
March 18, 2026

BTLabs report
IF-824-QSA-TR006-BTL2649-03

The certificate reports potency of 5 mg (100.6%) within its 90–110% specification. Its 1:17.7 peptide-to-excipients ratio is outside the stated recommended range of 1:2 to 1:10. Results apply only to the sample as received; this site has not independently authenticated the report or matched other inventory to this lot.

View original two-page BTLabs certificate ↗

SUPPLIER-PROVIDED ORIGINAL CERTIFICATE

Tesamorelin · 5 mg · Lot 57573

Reported HPLC purity
99.6%

Date tested
March 18, 2026

BTLabs report
IF-824-QSA-TR006-BTL2649-04

The certificate reports potency of 5.5 mg (110.8%), above its stated 90–110% specification; the peptide-to-excipients ratio is 1:8.2, within the stated recommended range. Results apply only to the sample as received; this site has not independently authenticated the report or matched other inventory to this lot.

View original two-page BTLabs certificate ↗

SUPPLIER-PROVIDED ORIGINAL CERTIFICATE

VIP · 10 mg · Lot 21699

Reported HPLC purity
99.7%

Date tested
March 18, 2026

BTLabs report
IF-824-QSA-TR006-BTL2649-06

The certificate reports potency of 10.8 mg (108.3%) and a peptide-to-excipients ratio of 1:3.9, within its stated ranges. Results apply only to the sample as received; this site has not independently authenticated the report or matched other inventory to this lot.

View original two-page BTLabs certificate ↗

SUPPLIER-PROVIDED ORIGINAL CERTIFICATE

5-Amino-1MQ · 10 mg · Lot 46721

Reported HPLC purity
99.7%

Date tested
March 2, 2026

BTLabs report
IF-824-QSA-TR006-2026-127-01

The certificate reports potency of 10.7 mg (106.9%) and a peptide-to-excipients ratio of 1:4.2, within its stated ranges. Results apply only to the sample as received; this site has not independently authenticated the report or matched other inventory to this lot.

View original two-page BTLabs certificate ↗

SUPPLIER-PROVIDED ORIGINAL CERTIFICATE

AICAR · 50 mg · Lot 70957

Reported HPLC purity
99.9%

Date tested
March 2, 2026

BTLabs report
IF-824-QSA-TR006-2026-127-02

The certificate reports potency of 53.7 mg (107.4%) within its stated 90–110% specification. Its 1:0.9 peptide-to-excipients ratio is below the stated recommended range of 1:2 to 1:10. Results apply only to the sample as received; this site has not independently authenticated the report or matched other inventory to this lot.

View original two-page BTLabs certificate ↗

SUPPLIER-PROVIDED ORIGINAL CERTIFICATE

AOD-9604 · 5 mg · Lot 97508

Reported HPLC purity
99.7%

Date tested
March 2, 2026

BTLabs report
IF-824-QSA-TR006-2026-127-03

The certificate reports potency of 5.5 mg (109.1%) and a peptide-to-excipients ratio of 1:7.5, within its stated ranges. Results apply only to the sample as received; this site has not independently authenticated the report or matched other inventory to this lot.

View original two-page BTLabs certificate ↗

SUPPLIER-PROVIDED ORIGINAL CERTIFICATE

Cagrilintide / Semaglutide · 10 mg · Lot 27161

Reported HPLC purity
99.5%

Date tested
March 2, 2026

BTLabs report
IF-824-QSA-TR006-2026-127-01

The certificate reports component potency values of Cagrilintide 5.8 mg (58.3%) and Semaglutide 4.9 mg (48.5%) against the 10 mg blend label. It reports a combined peptide-to-excipients ratio of 1:6.2, within its stated ratio range; component values are shown as printed. Results apply only to the sample as received; this site has not independently authenticated the report or matched other inventory to this lot.

View original two-page BTLabs certificate ↗

SUPPLIER-PROVIDED ORIGINAL CERTIFICATE

Cagrilintide · 10 mg · Lot 79433

Reported HPLC purity
99.8%

Date tested
March 2, 2026

BTLabs report
IF-824-QSA-TR006-2026-127-09

The certificate reports potency of 10.8 mg (107.6%) and a peptide-to-excipients ratio of 1:3.5, within its stated ranges. Results apply only to the sample as received; this site has not independently authenticated the report or matched other inventory to this lot.

View original two-page BTLabs certificate ↗

SUPPLIER-PROVIDED ORIGINAL CERTIFICATE

CJC-1295 DAC · 5 mg · Lot 56991

Reported HPLC purity
99.8%

Date tested
March 2, 2026

BTLabs report
IF-824-QSA-TR006-2026-127-15

The certificate reports potency of 6.2 mg (124.5%), above its stated 90–110% specification. The peptide-to-excipients ratio is 1:8.7, within the stated recommended range. Results apply only to the sample as received; this site has not independently authenticated the report or matched other inventory to this lot.

View original two-page BTLabs certificate ↗

SUPPLIER-PROVIDED ORIGINAL CERTIFICATE

CJC-1295 no-DAC / Ipamorelin · 10 mg blend · Lot 83775

Reported HPLC purity
99.9%

Date tested
March 2, 2026

BTLabs report
IF-824-QSA-TR006-2026-127-14

The certificate reports separate component potency results: Ipamorelin 5.2 mg (51.6%) and CJC-1295 6.9 mg (69.1%) against the 10 mg blend label. It reports a peptide-to-excipients ratio of 1:4.8. Component values are listed as printed in the source. Results apply only to the sample as received; this site has not independently authenticated the report or matched other inventory to this lot.

View original two-page BTLabs certificate ↗

SUPPLIER-PROVIDED ORIGINAL CERTIFICATE

CJC-1295 no-DAC · 5 mg · Lot 29563

Reported HPLC purity
99.7%

Date tested
March 2, 2026

BTLabs report
IF-824-QSA-TR006-2026-127-13

The certificate reports potency of 5.1 mg (102.1%) and a peptide-to-excipients ratio of 1:8.9, within its stated ranges. Results apply only to the sample as received; this site has not independently authenticated the report or matched other inventory to this lot.

View original two-page BTLabs certificate ↗

SUPPLIER-PROVIDED ORIGINAL CERTIFICATE

Cortagen · 20 mg · Lot 59968

Reported HPLC purity
99.7%

Date tested
March 2, 2026

BTLabs report
IF-824-QSA-TR006-2026-127-71

The certificate reports potency of 21 mg (105.1%) within its stated 90–110% specification. Its peptide-to-excipients ratio is 1:1.9, below the stated recommended range of 1:2 to 1:10. Results apply only to the sample as received; this site has not independently authenticated the report or matched other inventory to this lot.

View original two-page BTLabs certificate ↗

SUPPLIER-PROVIDED ORIGINAL CERTIFICATE

DSIP · 10 mg · Lot 25817

Reported HPLC purity
99.9%

Date tested
March 2, 2026

BTLabs report
IF-824-QSA-TR006-2026-127-16

The certificate reports potency of 10.1 mg (100.8%) and a peptide-to-excipients ratio of 1:4.3, within its stated ranges. Results apply only to the sample as received; this site has not independently authenticated the report or matched other inventory to this lot.

View original two-page BTLabs certificate ↗

SUPPLIER-PROVIDED ORIGINAL CERTIFICATE

DSIP · 5 mg · Lot 78142

Reported HPLC purity
99.9%

Date tested
March 2, 2026

BTLabs report
IF-824-QSA-TR006-2026-127-17

The certificate reports potency of 5 mg (99.4%) and a peptide-to-excipients ratio of 1:9.1, within its stated ranges. Results apply only to the sample as received; this site has not independently authenticated the report or matched other inventory to this lot.

View original two-page BTLabs certificate ↗

SUPPLIER-PROVIDED ORIGINAL CERTIFICATE

Epithalon · 10 mg · Lot 72578

Reported HPLC purity
99.6%

Date tested
March 2, 2026

BTLabs report
IF-824-QSA-TR006-2026-127-18

The certificate reports potency of 11.8 mg (118.3%), above its stated 90–110% specification. Its peptide-to-excipients ratio is 1:3.6, within the stated recommended range. Results apply only to the sample as received; this site has not independently authenticated the report or matched other inventory to this lot.

View original two-page BTLabs certificate ↗

SUPPLIER-PROVIDED ORIGINAL CERTIFICATE

GHK-Cu · 100 mg · Lot 53981

Reported HPLC purity
99.7%

Date tested
March 2, 2026

BTLabs report
IF-824-QSA-TR006-2026-127-19

The certificate reports potency of 108.3 mg (108.3%) within its stated 90–110% specification. Its 1:1.1 peptide-to-excipients ratio is below the stated recommended range of 1:2 to 1:10. Results apply only to the sample as received; this site has not independently authenticated the report or matched other inventory to this lot.

View original two-page BTLabs certificate ↗

SUPPLIER-PROVIDED ORIGINAL CERTIFICATE

GHK-Cu · 50 mg · Lot 56463

Reported HPLC purity
99.7%

Date tested
March 2, 2026

BTLabs report
IF-824-QSA-TR006-2026-127-20

The certificate reports potency of 59.6 mg (119.2%), above its stated 90–110% specification. Its peptide-to-excipients ratio is 1:2.6, within the stated recommended range. Results apply only to the sample as received; this site has not independently authenticated the report or matched other inventory to this lot.

View original two-page BTLabs certificate ↗

SUPPLIER-PROVIDED ORIGINAL CERTIFICATE

GLOW · 70 mg · Lot 63250

Reported HPLC purity
99.6%

Date tested
March 2, 2026

BTLabs report
IF-824-QSA-TR006-2026-127-21

The certificate lists component assays: GHK-Cu 61.2 mg (87.4%), BPC-157 7.4 mg (10.6%), and TB-500 5.2 mg (7.5%). It reports a peptide-to-excipients ratio of 1:1.2, below the stated recommended range of 1:2 to 1:10. Values are presented as printed in the report. Results apply only to the sample as received; this site has not independently authenticated the report or matched other inventory to this lot.

View original two-page BTLabs certificate ↗

SUPPLIER-PROVIDED ORIGINAL CERTIFICATE

GLP1-S / Semaglutide · 10 mg · Lot 30195

Reported HPLC purity
99.9%

Date tested
March 2, 2026

BTLabs report
IF-824-QSA-TR006-2026-127-45

The certificate reports potency of 9.5 mg (95%) and a peptide-to-excipients ratio of 1:4.8, within its stated ranges. The supplied filename identifies the record as GLP1-S. Results apply only to the sample as received; this site has not independently authenticated the report or matched other inventory to this lot.

View original two-page BTLabs certificate ↗

SUPPLIER-PROVIDED ORIGINAL CERTIFICATE

GLP1-S / Semaglutide · 20 mg · Lot 25765

Reported HPLC purity
99.8%

Date tested
March 2, 2026

BTLabs report
IF-824-QSA-TR006-2026-127-46

The certificate reports potency of 20.2 mg (101.2%) and a peptide-to-excipients ratio of 1:2.9, within its stated ranges. The supplied filename identifies the record as GLP1-S. Results apply only to the sample as received; this site has not independently authenticated the report or matched other inventory to this lot.

View original two-page BTLabs certificate ↗

SUPPLIER-PROVIDED ORIGINAL CERTIFICATE

GLP2-T / Tirzepatide · 10 mg · Lot 45543 · Report 63

Reported HPLC purity
99.6%

Date tested
March 2, 2026

BTLabs report
IF-824-QSA-TR006-2026-127-63

This is a second supplied report for lot 45543, with a distinct report number and BT Sample ID from the other listed lot 45543 certificate. It reports potency of 9.9 mg (99%) and a peptide-to-excipients ratio of 1:8.7, within its stated ranges. Results apply only to the sample as received; this site has not independently authenticated the report or matched other inventory to this lot.

View original two-page BTLabs certificate ↗

SUPPLIER-PROVIDED ORIGINAL CERTIFICATE

GLP2-T / Tirzepatide · 30 mg · Lot 37539

Reported HPLC purity
99.7%

Date tested
March 2, 2026

BTLabs report
IF-824-QSA-TR006-2026-127-65

The certificate reports potency of 33.9 mg (113.2%), above its stated 90–110% specification. The peptide-to-excipients ratio is 1:2.8, within its stated recommended range. Results apply only to the sample as received; this site has not independently authenticated the report or matched other inventory to this lot.

View original two-page BTLabs certificate ↗

SUPPLIER-PROVIDED ORIGINAL CERTIFICATE

GLP2-T / Tirzepatide · 5 mg · Lot 98146

Reported HPLC purity
99.5%

Date tested
March 2, 2026

BTLabs report
IF-824-QSA-TR006-2026-127-66

The certificate reports potency of 5.4 mg (108%) within its stated 90–110% specification. Its 1:15.5 peptide-to-excipients ratio is outside the stated recommended range of 1:2 to 1:10. Results apply only to the sample as received; this site has not independently authenticated the report or matched other inventory to this lot.

View original two-page BTLabs certificate ↗

SUPPLIER-PROVIDED ORIGINAL CERTIFICATE

GLP3-R / Retatrutide · 10 mg · Lot 80403 · Report 38

Reported HPLC purity
99.6%

Date tested
March 2, 2026

BTLabs report
IF-824-QSA-TR006-2026-127-38

This is a distinct supplied report for lot 80403 with a different report number and BT Sample ID from the other listed certificate. It reports potency of 10.4 mg (104.4%) and a peptide-to-excipients ratio of 1:6.8, within its stated ranges. Results apply only to the sample as received; this site has not independently authenticated the report or matched other inventory to this lot.

View original two-page BTLabs certificate ↗

SUPPLIER-PROVIDED ORIGINAL CERTIFICATE

GLP3-R / Retatrutide · 20 mg · Lot 74215 · Report 39

Reported HPLC purity
99.8%

Date tested
March 2, 2026

BTLabs report
IF-824-QSA-TR006-2026-127-39

This is a distinct supplied report for lot 74215 with a different report number and BT Sample ID from the other listed certificate. It reports potency of 21 mg (105.2%) and a peptide-to-excipients ratio of 1:4.4, within its stated ranges. Results apply only to the sample as received; this site has not independently authenticated the report or matched other inventory to this lot.

View original two-page BTLabs certificate ↗

SUPPLIER-PROVIDED ORIGINAL CERTIFICATE

GLP3-R / Retatrutide · 30 mg · Lot 46633 · Report 40

Reported HPLC purity
99.6%

Date tested
March 2, 2026

BTLabs report
IF-824-QSA-TR006-2026-127-40

This is a distinct supplied report for lot 46633 with a different report number and BT Sample ID from the other listed certificate. It reports potency of 29.4 mg (98.2%) and a peptide-to-excipients ratio of 1:3.3, within its stated ranges. Results apply only to the sample as received; this site has not independently authenticated the report or matched other inventory to this lot.

View original two-page BTLabs certificate ↗

SUPPLIER-PROVIDED ORIGINAL CERTIFICATE

GLP3-R / Retatrutide · 50 mg · Lot 21549

Reported HPLC purity
99.8%

Date tested
March 2, 2026

BTLabs report
IF-824-QSA-TR006-2026-127-42

The certificate reports potency of 53.4 mg (106.8%) within its stated 90–110% specification. Its 1:1 peptide-to-excipients ratio is below the stated recommended range of 1:2 to 1:10. Results apply only to the sample as received; this site has not independently authenticated the report or matched other inventory to this lot.

View original two-page BTLabs certificate ↗

SUPPLIER-PROVIDED ORIGINAL CERTIFICATE

GLP3-R / Retatrutide · 5 mg · Lot 85555

Reported HPLC purity
99.4%

Date tested
March 2, 2026

BTLabs report
IF-824-QSA-TR006-2026-127-41

The certificate reports potency of 4.8 mg (95.4%) and a 1:21.8 peptide-to-excipients ratio, outside its stated recommended range of 1:2 to 1:10. Results apply only to the sample as received; this site has not independently authenticated the report or matched other inventory to this lot.

View original two-page BTLabs certificate ↗

SUPPLIER-PROVIDED ORIGINAL CERTIFICATE

Ipamorelin · 10 mg · Lot 84704

Reported HPLC purity
99.8%

Date tested
March 2, 2026

BTLabs report
IF-824-QSA-TR006-2026-127-22

The certificate reports potency of 10 mg (100.1%) and a peptide-to-excipients ratio of 1:9.7, within its stated ranges. Results apply only to the sample as received; this site has not independently authenticated the report or matched other inventory to this lot.

View original two-page BTLabs certificate ↗

SUPPLIER-PROVIDED ORIGINAL CERTIFICATE

Ipamorelin · 5 mg · Lot 51036

Reported HPLC purity
99.8%

Date tested
March 2, 2026

BTLabs report
IF-824-QSA-TR006-2026-127-23

The certificate reports potency of 5.3 mg (105.4%) within its 90–110% specification. Its 1:18.6 peptide-to-excipients ratio is outside the stated recommended range of 1:2 to 1:10. Results apply only to the sample as received; this site has not independently authenticated the report or matched other inventory to this lot.

View original two-page BTLabs certificate ↗

SUPPLIER-PROVIDED ORIGINAL CERTIFICATE

Kisspeptin · 10 mg · Lot 80694

Reported HPLC purity
99.9%

Date tested
March 2, 2026

BTLabs report
IF-824-QSA-TR006-2026-127-24

The certificate reports potency of 10.2 mg (101.9%) and a peptide-to-excipients ratio of 1:6.6, within its stated ranges. Results apply only to the sample as received; this site has not independently authenticated the report or matched other inventory to this lot.

View original two-page BTLabs certificate ↗

SUPPLIER-PROVIDED ORIGINAL CERTIFICATE

KLOW · 80 mg · Lot 78928

Reported HPLC purity
99.7%

Date tested
March 2, 2026

BTLabs report
IF-824-QSA-TR006-2026-127-25

The certificate lists component assays: GHK-Cu 62.2 mg (77.7%), KPV 8.9 mg (11.2%), BPC-157 10.8 mg (13.5%), and TB-500 9.2 mg (11.5%). Its 1:1.9 peptide-to-excipients ratio is below the stated recommended range of 1:2 to 1:10. Values are shown as printed in the report. Results apply only to the sample as received; this site has not independently authenticated the report or matched other inventory to this lot.

View original two-page BTLabs certificate ↗

SUPPLIER-PROVIDED ORIGINAL CERTIFICATE

MOTS-C · 10 mg · Lot 60100

Reported HPLC purity
99.8%

Date tested
March 2, 2026

BTLabs report
IF-824-QSA-TR006-2026-127-31

The certificate reports potency of 10.5 mg (104.9%) and a peptide-to-excipients ratio of 1:6.7, within its stated ranges. Results apply only to the sample as received; this site has not independently authenticated the report or matched other inventory to this lot.

View original two-page BTLabs certificate ↗

SUPPLIER-PROVIDED ORIGINAL CERTIFICATE

Melanotan II · 10 mg · Lot 28174

Reported HPLC purity
99.5%

Date tested
March 2, 2026

BTLabs report
IF-824-QSA-TR006-2026-127-30

The certificate reports potency of 10.7 mg (107.5%) and a peptide-to-excipients ratio of 1:4.6, within its stated ranges. Results apply only to the sample as received; this site has not independently authenticated the report or matched other inventory to this lot.

View original two-page BTLabs certificate ↗

SUPPLIER-PROVIDED ORIGINAL CERTIFICATE

Melanotan I · 10 mg · Lot 22186

Reported HPLC purity
99.7%

Date tested
March 2, 2026

BTLabs report
IF-824-QSA-TR006-2026-127-29

The certificate reports potency of 10.4 mg (103.7%) and a peptide-to-excipients ratio of 1:4.6, within its stated ranges. Results apply only to the sample as received; this site has not independently authenticated the report or matched other inventory to this lot.

View original two-page BTLabs certificate ↗

SUPPLIER-PROVIDED ORIGINAL CERTIFICATE

Mazdutide · 5 mg · Lot 98385

Reported HPLC purity
99.6%

Date tested
March 2, 2026

BTLabs report
IF-824-QSA-TR006-2026-127-28

The certificate reports potency of 5.4 mg (108.5%) within its stated 90–110% specification. Its 1:12.3 peptide-to-excipients ratio is outside the stated recommended range of 1:2 to 1:10. Results apply only to the sample as received; this site has not independently authenticated the report or matched other inventory to this lot.

View original two-page BTLabs certificate ↗

SUPPLIER-PROVIDED ORIGINAL CERTIFICATE

Mazdutide · 10 mg · Lot 56636

Reported HPLC purity
99.5%

Date tested
March 2, 2026

BTLabs report
IF-824-QSA-TR006-2026-127-27

The certificate reports potency of 11.1 mg (110.7%), slightly above its stated 90–110% specification. The peptide-to-excipients ratio is 1:6.3, within the stated recommended range. Results apply only to the sample as received; this site has not independently authenticated the report or matched other inventory to this lot.

View original two-page BTLabs certificate ↗

SUPPLIER-PROVIDED ORIGINAL CERTIFICATE

MOTS-C · 20 mg · Lot 52610

Reported HPLC purity
99.9%

Date tested
March 2, 2026

BTLabs report
IF-824-QSA-TR006-2026-127-32

The certificate reports potency of 22.5 mg (112.4%), above its stated 90–110% specification; the peptide-to-excipients ratio is 1:2.7, within its stated recommendation. Results apply only to the sample as received; this site has not independently authenticated the report or matched other inventory to this lot.

View original two-page BTLabs certificate ↗

SUPPLIER-PROVIDED ORIGINAL CERTIFICATE

MOTS-C · 40 mg · Lot 39542

Reported HPLC purity
99.9%

Date tested
March 2, 2026

BTLabs report
IF-824-QSA-TR006-2026-127-33

The certificate reports potency of 42.9 mg (107.3%) within its stated 90–110% specification. Its 1:1.5 peptide-to-excipients ratio is below the stated recommended range of 1:2 to 1:10. Results apply only to the sample as received; this site has not independently authenticated the report or matched other inventory to this lot.

View original two-page BTLabs certificate ↗

SUPPLIER-PROVIDED ORIGINAL CERTIFICATE

NAD · 500 mg · Lot 45018

Reported HPLC purity
99.9%

Date tested
March 2, 2026

BTLabs report
IF-824-QSA-TR006-2026-127-74

The certificate reports potency of 482.5 mg (96.5%) against its stated 90–110% specification and a peptide-to-excipients ratio of 1:0.3, below its stated recommended range of 1:2 to 1:10. Results apply only to the sample as received; this site has not independently authenticated the report or matched other inventory to this lot.

View original two-page BTLabs certificate ↗

SUPPLIER-PROVIDED ORIGINAL CERTIFICATE

Oxytocin · 10 mg · Lot 73586

Reported HPLC purity
99.4%

Date tested
March 2, 2026

BTLabs report
IF-824-QSA-TR006-2026-127-34

The certificate reports potency of 10.7 mg (106.8%) and a peptide-to-excipients ratio of 1:6.4, within its stated ranges. Results apply only to the sample as received; this site has not independently authenticated the report or matched other inventory to this lot.

View original two-page BTLabs certificate ↗

SUPPLIER-PROVIDED ORIGINAL CERTIFICATE

Oxytocin · 5 mg · Lot 66263

Reported HPLC purity
99.6%

Date tested
March 2, 2026

BTLabs report
IF-824-QSA-TR006-2026-127-35

The certificate reports potency of 4.9 mg (98.8%) and a peptide-to-excipients ratio of 1:10, at the upper end of its stated recommended range. Results apply only to the sample as received; this site has not independently authenticated the report or matched other inventory to this lot.

View original two-page BTLabs certificate ↗

SUPPLIER-PROVIDED ORIGINAL CERTIFICATE

TB-500 · 10 mg · Lot 90244

Reported HPLC purity
99.3%

Date tested
March 2, 2026

BTLabs report
IF-824-QSA-TR006-2026-127-57

The certificate reports potency of 10.3 mg (102.5%) and a peptide-to-excipients ratio of 1:6, within its stated ranges. Results apply only to the sample as received; this site has not independently authenticated the report or matched other inventory to this lot.

View original two-page BTLabs certificate ↗

SUPPLIER-PROVIDED ORIGINAL CERTIFICATE

Survodutide · 10 mg · Lot 46798

Reported HPLC purity
99.4%

Date tested
March 2, 2026

BTLabs report
IF-824-QSA-TR006-2026-127-56

The certificate reports potency of 9.8 mg (98.2%) and a peptide-to-excipients ratio of 1:6, within its stated ranges. Results apply only to the sample as received; this site has not independently authenticated the report or matched other inventory to this lot.

View original two-page BTLabs certificate ↗

SUPPLIER-PROVIDED ORIGINAL CERTIFICATE

SS-31 · 30 mg · Lot 92477

Reported HPLC purity
99.9%

Date tested
March 2, 2026

BTLabs report
IF-824-QSA-TR006-2026-127-54

The certificate reports potency of 35.2 mg (117.2%), above its stated 90–110% specification. The peptide-to-excipients ratio of 1:2 is within the stated recommended range. Results apply only to the sample as received; this site has not independently authenticated the report or matched other inventory to this lot.

View original two-page BTLabs certificate ↗

SUPPLIER-PROVIDED ORIGINAL CERTIFICATE

SS-31 · 10 mg · Lot 14476

Reported HPLC purity
99.9%

Date tested
March 2, 2026

BTLabs report
IF-824-QSA-TR006-2026-127-53

The certificate reports potency of 10.8 mg (108.5%) and a peptide-to-excipients ratio of 1:5.5, within its stated ranges. Results apply only to the sample as received; this site has not independently authenticated the report or matched other inventory to this lot.

View original two-page BTLabs certificate ↗

SUPPLIER-PROVIDED ORIGINAL CERTIFICATE

Sermorelin · 5 mg · Lot 57243

Reported HPLC purity
99.7%

Date tested
March 2, 2026

BTLabs report
IF-824-QSA-TR006-2026-127-51

The certificate reports potency of 4.8 mg (95%) within its stated 90–110% specification. Its 1:13.3 peptide-to-excipients ratio is outside the stated recommended range of 1:2 to 1:10. Results apply only to the sample as received; this site has not independently authenticated the report or matched other inventory to this lot.

View original two-page BTLabs certificate ↗

SUPPLIER-PROVIDED ORIGINAL CERTIFICATE

Tri-Heal · 45 mg · Lot 78609

Reported HPLC purity
99.7%

Date tested
March 2, 2026

BTLabs report
IF-824-QSA-TR006-2026-127-67

The report lists KPV 10.5 mg (23.4%), BPC-157 10.6 mg (23.5%), and TB-500 22.4 mg (49.8%). The listed total is 43.5 mg against a 45 mg label claim. Its peptide-to-excipients ratio is 1:1.4, outside the stated recommended range of 1:2 to 1:10. Results apply only to the sample as received; this site has not independently authenticated the report or matched other inventory to this lot.

View original two-page BTLabs certificate ↗

SUPPLIER-PROVIDED ORIGINAL CERTIFICATE

Tesamorelin / Ipamorelin · 10 mg · Lot 63747

Reported HPLC purity
99.9%

Date tested
March 2, 2026

BTLabs report
IF-824-QSA-TR006-2026-127-62

The report lists Ipamorelin 5.5 mg (55.3%) and Tesamorelin 5.8 mg (57.5%), totaling 11.3 mg against a 10 mg label claim, above the stated 90–110% potency specification. The peptide-to-excipients ratio is 1:5.4, within the stated recommended range. Results apply only to the sample as received; this site has not independently authenticated the report or matched other inventory to this lot.

View original two-page BTLabs certificate ↗

SUPPLIER-PROVIDED ORIGINAL CERTIFICATE

Tesamorelin · 20 mg · Lot 80804

Reported HPLC purity
99.8%

Date tested
March 2, 2026

BTLabs report
IF-824-QSA-TR006-2026-127-60

The certificate reports potency of 21.1 mg (105.5%) and a peptide-to-excipients ratio of 1:2.7, both within the report’s stated ranges. Results apply only to the sample as received; this site has not independently authenticated the report or matched other inventory to this lot.

View original two-page BTLabs certificate ↗

SUPPLIER-PROVIDED ORIGINAL CERTIFICATE

Tesamorelin · 10 mg · Lot 81625

Reported HPLC purity
99.7%

Date tested
March 2, 2026

BTLabs report
IF-824-QSA-TR006-2026-127-59

The certificate reports potency of 10.9 mg (109.3%) and a peptide-to-excipients ratio of 1:4.9, within the report’s stated ranges. Results apply only to the sample as received; this site has not independently authenticated the report or matched other inventory to this lot.

View original two-page BTLabs certificate ↗

SUPPLIER-PROVIDED ORIGINAL CERTIFICATE

TB-500 · 5 mg · Lot 42601

Reported HPLC purity
99.1%

Date tested
March 2, 2026

BTLabs report
IF-824-QSA-TR006-2026-127-58

The certificate reports potency of 5.4 mg (108.7%), within its stated 90–110% specification. Its 1:19.8 peptide-to-excipients ratio is outside the report’s stated recommended range of 1:2 to 1:10. Results apply only to the sample as received; this site has not independently authenticated the report or matched other inventory to this lot.

View original two-page BTLabs certificate ↗

Document provenance

These images were supplied by the store owner. The certificate summary is branded Pure Lab Peptides, and the source itself attributes laboratory testing to Chromate. Branding and laboratory attribution are shown as supplied; this site is independently operated.

The summary shows a QR code and source-report access information. Confirm the full source report and confirm the lot identity against your inventory before relying on this record. The chromatogram page states its source image was extracted from the original report.

Documentation questions: info@officialpurepeptides.com · (551) 327-6314.